|Heijnen, Ingmar A. F. M.||heijneni(at)uhbs.ch||Detail»|
|Speiser, Daniel Ernst||daniel.speiser(at)hospvd.ch||Detail»|
As a rule, a new president of SSAI is elected every two years by the general assembly. However, to assure continuity over longer periods, the future president elected and the past president are also part of the committee. The actual members are:
Professor Federica Sallusto, PhD, received her university degree as Doctor in Biology in 1988 from the University “La Sapienza”, Rome. She worked at the Department of Immunology, Italian National Institute of Health and at the Basel Institute for Immunology. Since 2000 she is group leader at the Institute for Research in Biomedicine, Bellinzona, Switzerland. Federica Sallusto has been working in the field of human dendritic cell and Tlymphocyte cell biology. She has described a method to generate immature dendritic cells from human monocytes, which is now widely used for therapeutic vaccination. She has studied human T helper cell differentiation focusing in particular on the relationship between migratory capacity and effector functions. This work led to the discovery that Th1 and Th2 cells express distinct sets of chemokine receptors and to the identification of central and effector subsets of memory T cells. In 1999 she received the Pharmacia Allergy Research Foundation Award. Federica Sallusto is SSAI president for the period 2013-2015.
Professor Peter Schmid-Grendelmeier, MD, graduated at the Universities of Fribourg and Zurich in 1985. After a broad residency in various disciplines he became a board certified specialist for allergology and clinical immunology and also dermatology at the university hospital of Zurich. He then spent two years performing experimental and clinical research on recombinant allergens at the Swiss Institute for Allergy and Asthma SIAF Davos. Since 2003 he has become associate professor and the acting head of the allergy unit of the university hospital of Zurich. His research focuses on epidemiological aspects and microbial effects in atopic dermatitis, where he has observed interesting auto-reactivity phenomenon’s caused by skin colonizing fungal elements. Other focus are the improvement of immunotherapy of allergies by using new techniques such as component-resolved allergen use, mastocytosis and hereditary angioedema. Finally, having worked several years in Latin America and eastern Africa, he is involved in several studies investigating the epidemiology and prevalence of allergic diseases in tropical areas. Besides other duties, Peter Schmid-Grendelmeier is past-president of the specialist commission FK of SSAI, chair of the dermatology section as well as chair of the task force for the European Knowledge test in Allergy and Clinical Immunology, both of the EAACI. Peter Schmid-Grendelmeier is president elect of SSAI for the period 2013-2015.
Professor Philippe Eigenmann, MD, is a pediatrician and allergist trained in Switzerland and in the USA (Johns Hopkins Hospital, Baltimore). He is currently head of Pediatric Allergy at the University Hospital of Geneva Switzerland. His main focus of research is food allergy with several ongoing studies, both clinical and in the laboratory. He is currently section editor in Pediatric Allergy and Immunology and in the Editorial Board of Allergy. In addition to his scientific activity, he has been the chair of the European Academy of Allergology and Clinical Immunology (EAACI) section on Pediatrics from 2003 to 2007, and is member of the EAACI Executive Committee (2009-2011 term). Dr Eigenmann is chair of the EAACI annual meeting 2012 in Geneva. He is also secretary of the EAACI-Clemens von Pirquet Foundation, a European foundation promoting research and education in pediatric allergy and immunology. Within the activity of the Foundation, he coordinates iPAC, the international pediatric allergy and asthma consortium. Philippe Eigenmann is the president past of SSAI for the period 2013-2015.
Professor Christoph Mueller, PhD, graduated from the University of Bern in Medical Microbiology and did his postgraduate training in experimental pathology with Professor Irv L. Weissman at Stanford University Medical Center in Palo Alto, USA.
He returned to the Department of Pathology at the University of Bern in 1989 and is now heading the Division of Experimental Pathology at the University of Bern. The main research interests of his group are the molecular and cellular events operative in immunopathologies, particularly, in the gastrointestinal tract (Crohn’s disease, ulcerative colitis) in patients and mouse models of these disorders, and the adaptations of the local adaptive and innate immune system to the antigen-rich environment of the intestinal mucosa. Christoph Mueller is the treasurer of SSAI.
Professor Carlo Chizzolini, MD, obtained his MD degree in 1979 at the School of Medicine, University of Parma, Italy, where he specialized in Allergy and Clinical Immunology in 1983. In the following 10 years he was involved in a research program aiming at the development of a malaria vaccine in Geneva, Gabon, equatorial Africa, and at the Centers of Disease Control and Prevention in Atlanta, GA, USA. Since April 1994 he is in the Division of Immunology and Allergy, Geneva University Hospital, where he cares for individuals suffering of systemic autoimmune diseases, particularly systemic lupus erythematosus, systemic vasculitis, and systemic sclerosis. He runs a research laboratory entitled: “Fibrosis and Inflammation” mostly involved in investigating the role of T cells and autoantibodies in inflammatory reactions leading to excessive fibrosis. He is the coordinator of the Swiss SLE cohort study and participates to international networks interested in autoimmune systemic disorders. He is president of the SSAI specialists commission FK for period 2013-1015. He has entered the FK in 2008 and is a member of the SSAI Committee since 2011.
Dr. Louis-François Debétaz, MD, received his degree at the University of Lausanne in 1985 and did his residency in surgery, pediatrics and mostly internal medicine in various hospitals in Switzerland. He received the FMH titel of specialist in internal medicine before training in allergy and clinical immunology at the CHUV in Lausanne, where he received the FMH titel for this specialty in 1997. He received in 1998 the price of the medical faculty of Lausanne for his thesis on St-Jude’s prosthetic valves. Since 1997, he works as a private practitioner in Lausanne and is a member of the Groupement Vaudois des Allergologues et Immunologues Clinique since 1999. He took the presidency of this association for one year in 2005. He joined the the specialists commission FK in 2004, was president from March 2011-April 2013 und is now president past for the period 2013-2015. He remains president of the commission professional politics and is a member of the SSAI commission for postgraduate education and for professional politics.
Professor Burkhard Ludewig, MD, is an Immunologist and acts currently as the head of the Medical Research Center and the Institute of Immunobiology at the Kantonsspital St. Gallen. My research interests are focused on the interaction of viruses with the innate and adaptive immune system and potential autoimmune sequelae resulting from viral infections. Furthermore, my laboratory has established translational approaches to develop novel vaccination methods and immunodiagnostic tools. I am affiliated with the VetSuisse faculty of the University of Zürich and hold the academic position of a Titularprofessor in the field of immunopathology. Further academic activities include teaching of biology students of the ETH Zürich and the University of Zürich in immunology, and supervising PhD students from the Life Science Zürich Graduate School in my laboratory.
I graduated in 1992 at the Faculty of Veterinary Medicine of the Free University (FU) Berlin, Germany, and received a Doctorate in Medicine in 1995 at the FU Berlin following a three year experimental work at the Robert-Koch Institute. Following two short postdoctoral positions at the Robert-Koch Institute and the Hebrew University of Jerusalem, I joined the Institute of Experimental Immunology at the University of Zürich in 1997 as a recipient of the postdoctoral fellowship from the Deutsche Forschungsgemeinschaft. In 2001, I habilitated at the University of Zürich and accepted a position as head of the laboratory research unit at the Kantonsspital St. Gallen in 2002. Subsequently, I could help to found the Institute of Immunobiology and shape the Medical Research Center at our hospital. In 2001, I co-founded the bio-pharmaceutical company Ganymed Pharmaceuticals AG, Mainz, and served a scientific advisor until 2008.
Professor Annette Oxenius, PhD, received her university degree in biochemistry at the University of Zurich in 1993 and in 1997 a PhD at the Institute of Experimental Immunology at the ETH Zurich. After a postdoc at the University of Oxford, UK, she was elected assistant professor for immunology at the Institute of Microbiology of the ETH in 2002 and was promoted to associate professor in 2007. Her research focuses on immune responses in the context of pathogenic viral and bacterial infections in experimental mouse models and in humans. In 2002 she received the “Förderungspreis” of the Swiss Society of Microbiology and in 2006 the Robert-Koch-“Förderpreis” and the EMBO Young Investigator Award. Annette Oxenius is member of the SSAI Committee since 2009 and president of the SSAI commission for Experimental Immunology CEI sind April 2013.
Professor Daniel E. Speiser, MD, is a clinician-scientist and a Member of the Ludwig Institute for Cancer Research, and leads the Clinical Tumor Immune-Biology Group and the Unit for Investigator-Initiated Oncology Studies at the University Hospital Lausanne, Switzerland. He performs clinical studies representing a step-by-step development towards more efficient cancer vaccines, with the aim to identify vaccine components contributing to protective T cell responses. Research of his group is focused on activation, differentiation and function of antigen specific human T cells, with special emphasis on ex vivo analyses of immune activatory and inhibitory pathways and their relation to parameters of cancer biology and inflammation. Daniel graduated in 1982 and received a Doctorate in Medicine in 1986 at the University of Zürich, Switzerland. He completed his clinical education in internal medicine, immunology and (hemato-)oncology. Then, he trained for five years in the laboratory of R.M. Zinkernagel, specializing in infectious and tumor immunity. Subsequently, he extended his experience to basic and clinical immunology and habilitated at the University of Geneva in 1995. During his career, he realized many R&D projects, for example by developing experimental immunotherapy in mouse models with naturally arising pancreatic tumors, with P.S. Ohashi and T.W. Mak at the Ontario Cancer Institute and the University of Toronto, Canada. Daniel promotes academic bio-medical progress at local, national and international levels. One of his major aims is to move clinical research up the value chain, which is definitely needed in Switzerland, and required for state-of-the-art education, development and optimal patient care at academic centers.
Dr. Madeleine Bauer from Olten is member of the Committee since April 2013.
Dr. Ingmar Heijnen is member of the Committee and president of the CLD Commission Laboratory Diagnostics since April 2013.